Nuclear proteostasis imbalance in laminopathy-associated premature aging diseases

FASEB J. 2023 Aug;37(8):e23116. doi: 10.1096/fj.202300878R.

Abstract

Laminopathies are a group of rare genetic disorders with heterogeneous clinical phenotypes such as premature aging, cardiomyopathy, lipodystrophy, muscular dystrophy, microcephaly, epilepsy, and so on. The cellular phenomena associated with laminopathy invariably show disruption of nucleoskeleton of lamina due to deregulated expression, localization, function, and interaction of mutant lamin proteins. Impaired spatial and temporal tethering of lamin proteins to the lamina or nucleoplasmic aggregation of lamins are the primary molecular events that can trigger nuclear proteotoxicity by modulating differential protein-protein interactions, sequestering quality control proteins, and initiating a cascade of abnormal post-translational modifications. Clearly, laminopathic cells exhibit moderate to high nuclear proteotoxicity, raising the question of whether an imbalance in nuclear proteostasis is involved in laminopathic diseases, particularly in diseases of early aging such as HGPS and laminopathy-associated premature aging. Here, we review nuclear proteostasis and its deregulation in the context of lamin proteins and laminopathies.

Keywords: laminopathies; lamins; mutation; nuclear proteostasis; proteotoxicity.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aging, Premature* / genetics
  • Aging, Premature* / metabolism
  • Cell Nucleus / metabolism
  • Humans
  • Lamin Type A / genetics
  • Lamin Type A / metabolism
  • Laminopathies* / metabolism
  • Lamins / genetics
  • Lamins / metabolism
  • Mutation
  • Nuclear Lamina / genetics
  • Nuclear Lamina / metabolism
  • Proteostasis

Substances

  • Lamins
  • Lamin Type A